Cargando…

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

AIMS: Biomarkers are increasingly being used in the management of patients with chronic heart failure (HF). Galectin-3 is a recently developed biomarker associated with fibrosis and inflammation, and it may play a role in cardiac remodeling in HF. We determined its prognostic value in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lok, Dirk J. A., Van Der Meer, Peter, de la Porte, Pieta W. Bruggink-André, Lipsic, Erik, Van Wijngaarden, Jan, Hillege, Hans L., van Veldhuisen, Dirk J.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858799/ https://www.ncbi.nlm.nih.gov/pubmed/20130888 http://dx.doi.org/10.1007/s00392-010-0125-y

Ejemplares similares

Prognostic value of galectin-3, a novel marker of fibrosis
por: Lok, Dirk J., et al.
Publicado: (2010)

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
por: de Boer, Rudolf A, et al.
Publicado: (2011)

Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2010)

Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2012)

A re-appraisal of volume status and renal function impairment in chronic heart failure: combined effects of pre-renal failure and venous congestion on renal function
por: Sinkeler, Steef J., et al.
Publicado: (2011)

Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure
por: Screever, Elles M., et al.
Publicado: (2023)

Current and novel renal biomarkers in heart failure
por: Damman, Kevin, et al.
Publicado: (2011)

Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction
por: Tromp, Jasper, et al.
Publicado: (2017)

Pro‐gastrin‐releasing peptide and outcome in patients with heart failure and anaemia: results from the RED‐HF study
por: Ueland, Thor, et al.
Publicado: (2018)

Plasma levels of alpha-1-antichymotrypsin are elevated in patients with chronic heart failure, but are of limited prognostic value
por: Lok, S. I., et al.
Publicado: (2014)

Ventricular tachyarrhythmia detection by implantable loop recording in patients with heart failure and preserved ejection fraction: the VIP‐HF study
por: van Veldhuisen, Dirk J., et al.
Publicado: (2020)

Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology
por: Alnuwaysir, Ridha I. S., et al.
Publicado: (2021)

New roles for renin and prorenin in heart failure and cardiorenal crosstalk
por: Schroten, Nicolas F., et al.
Publicado: (2011)

Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS‐HF and RALES
por: Yeoh, Su E., et al.
Publicado: (2021)

Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF
por: Ueland, Thor, et al.
Publicado: (2021)

A Genome-Wide Association Study of Circulating Galectin-3
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Klaassen, Sebastiaan HC, et al.
Publicado: (2020)

Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?
por: Bomer, Nils, et al.
Publicado: (2022)

ACE-inhibitors, Beta-blockers or the Combination in Heart Failure: Is It Just an A–B–C ?: EDITORIAL to: Effects of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure by Rosenberg et al.
por: de Boer, Rudolf A., et al.
Publicado: (2008)

Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations
por: Vegter, Eline L., et al.
Publicado: (2017)

Safety and Tolerability of Sodium Thiosulfate in Patients with an Acute Coronary Syndrome Undergoing Coronary Angiography: A Dose-Escalation Safety Pilot Study (SAFE-ACS)
por: de Koning, Marie-Sophie L. Y., et al.
Publicado: (2020)

Renal dysfunction is associated with shorter telomere length in heart failure
por: Wong, Liza S. M., et al.
Publicado: (2009)

Prognostic Value of Serial Galectin‐3 Measurements in Patients With Acute Heart Failure
por: van Vark, Laura C., et al.
Publicado: (2017)

Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF
por: Sharma, Abhinav, et al.
Publicado: (2023)

A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
por: Linssen, G. C. M., et al.
Publicado: (2018)

What should the C (‘congestive heart failure’) represent in the CHA(2)DS(2)‐VASc score?
por: Mulder, Bart A., et al.
Publicado: (2020)

Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fraction
por: Schroten, Nicolas F., et al.
Publicado: (2015)

The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach
por: Hoes, Martijn F., et al.
Publicado: (2019)

Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure
por: van den Berg, Pieter F., et al.
Publicado: (2023)

Galectin-3 as an Arrhythmogenic Predictive Marker for Heart Failure
por: Inoue, Keiko, et al.
Publicado: (2022)

Heart Failure and Pancreas Exocrine Insufficiency: Pathophysiological Mechanisms and Clinical Point of View
por: Dams, Olivier C., et al.
Publicado: (2022)

Selenium and outcome in heart failure
por: Bomer, Nils, et al.
Publicado: (2019)

Treatment of heart failure with ACE inhibitors and beta-blockers: What is next? Aldosterone receptor antagonists?
por: van der Horst, Iwan C. C., et al.
Publicado: (2007)

A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial
por: Mehra, Mandeep R, et al.
Publicado: (2019)

Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON‐HF
por: Mooney, Leanne, et al.
Publicado: (2021)

Statins in the Treatment of Chronic Heart Failure: A Systematic Review
por: van der Harst, Pim, et al.
Publicado: (2006)

Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial
por: Haver, Vincent G., et al.
Publicado: (2015)

Clinical implications of low estimated protein intake in patients with heart failure
por: Streng, Koen W., et al.
Publicado: (2022)

Geriatric rehabilitation in older patients with cardiovascular disease: a feasibility study
por: van Dam van Isselt, Eléonore F., et al.
Publicado: (2018)

Cancer and heart disease: associations and relations
por: de Boer, Rudolf A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fiau7h3ufl1vhcrg312a88mrnq